Status: affected by both circulating vaccine-derived poliovirus type 2 (cVDPV2) and type 3 (cVDPV3)
Israel is affected by co-circulation of both cVDPV2 and cVDPV3. One case due to cVDPV3 was confirmed in the country; while cVDPV2 has been isolated from environmental samples only.
Polio this week in Israel
- No case of circulating vaccine-derived poliovirus type 3 (cVDPV3) was reported this week. There is one case reported in 2022.
- The country has been confirmed as affected by both cVDPV2 and cVDPV3.
International Health Regulations
Countries affected by poliovirus circulation are subject to temporary recommendations issued by the Emergency Committee of the International Health Regulations on Poliovirus, under the auspices of the Public Health Emergency of International Concern. The latest report by the Committee is as of 1 November 2022.
WHO’s International Travel and Health recommends that all travellers to polio-affected areas be fully vaccinated against polio. Residents (and visitors for more than 4 weeks) from infected areas should receive an additional dose of OPV or inactivated polio vaccine (IPV) within 4 weeks to 12 months of travel.